retatrutide clinical trials weight loss results trial 2024 2025 press release Lilly's retatrutide shows 28% weight loss Experimental drug Retatrutide shows promising
Description
The new drugs, a category called GLP-1 receptor agonists, are so effective, and already in such wide use, that they are beginning to broadly impact food and beverage sales
Dexcom G7: the first and only continuous glucose monitoring (CGM) system with medication logging
Several types of GLP-1 agonists are available
He emphasised that the drugs act as an adjunct, enhancing the effectiveness of broader diabetes management rather than functioning as a standalone solution
Statements about BioTrust GLP-1 Elevate have not been evaluated by the U.S
